Vícečetné zhoubné novotvary: Ukazatel zdraví a nákladů péče v onkologii

Investor logo

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Science. Official publication website can be found on muni.cz.
Title in English Multiple malignant neoplasms: The burden of health status and health care costs in oncology
Authors

GERYK Edvard BENDOVÁ Marie KUBÍČEK Petr ŠTAMPACH Radim ODEHNAL Jakub KOŠKA Petr HOLUB Jiří KONEČNÝ Milan

Year of publication 2008
Type Article in Periodical
Magazine / Source Zdravotnictví v České republice
MU Faculty or unit

Faculty of Science

Citation
Field Earth magnetism, geography
Keywords cancers; number of surviving; multiple malignant neoplasms (MMN); geographical distribution; prediction of trends; health expenditures
Description Multiple malignant neoplasms (MMN) belong to feared complications of the patient's therapy. With their different histology and topography characteristics the cause of their occurrence is considered to be in penetrative or fierce treatment of primary neoplasm and in hereditary predisposition. From the difference between cases and persons registered in the Czech Cancer Registry since May 1976 and living with cancer of dg. C00-D09 there was determined the trend of MMN in men and women to 31. 12. in the years 1989-2005 in the Czech Republic and 14 regions. The introduced summary does not enable to identify first and following cancers and their timing relationship. To their estimation we used the list of cancers with the highest increase of prevalance in 1989-2005. With the continuing diagnostics, treatment and mandatory reporting we can expect the rising numbers of cancer prevalence cases and the MMN will reach 20% in male and 14% in female as of 31. 12. 2010. It means for both sexes increasing to 98 thousand, from which 20 thousand MMN in productive age with the higher healthcare expenditures in oncology. Their burden increased from 7222 billion CZK to 9013 billion CZK during 2000-2005. In continued trend of expenditures of neoplasms they can reach nearly 11 billion CZK in 2010 with the number of 595 thousand surviving cancer cases.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.